In advanced age, decreased CD8 + cytotoxic T-lymphocyte (CTL) responses to novel pathogens and cancer is paralleled by a decline in the number and function of naïve CTL precursors (CTLp). Although the age-related fall in CD8 + T-cell numbers is well established, neither the underlying mechanisms nor the extent of variation for different epitope specificities have been defined. Furthermore, naïve CD8 + T cells expressing high levels of CD44 accumulate with age, but it is unknown whether this accumulation reflects their preferential survival or an age-dependent driver of CD8 + T-cell proliferation. Here, we track the number and phenotype of four influenza A virus (IAV)-specific CTLp populations in naïve C57BL/6 (B6) mice during aging, and compare T-cell receptor (TCR) clonal diversity for the CD44hi and CD44lo subsets of one such population. We show differential onset of decline for several IAV-specific CD8 + T-cell populations with advanced age that parallel age-associated changes in the B6 immunodominance hierarchy, suggestive of distinct impacts of aging on different epitope-specific populations. Despite finding no evidence of clonal expansions in an aged, epitope-specific TCR repertoire, nonrandom alterations in TCR usage were observed, along with elevated CD5 and CD8 coreceptor expression. Collectively, these data demonstrate that naïve CD8 + T cells expressing markers of heightened selfrecognition are selectively retained, but not clonally expanded, during aging.critical for the control of viruses and tumors, specific defects are likely to contribute substantially to overall immune dysfunction. Normal aging is associated with increased health risk, as vaccine efficacy wanes and susceptibility to, and severity of, a variety of infections and malignancies is enhanced (1, 2). Whereas aging compromises a number of arms of the immune system (3), studies in mice and humans have demonstrated deficits that are intrinsic to naïve CTL populations (4-6). Thus, a complete understanding of both age-related CTL deficiencies and the underlying mechanisms is critical.The magnitude of the response, the diversity of T-cell receptor (TCR)-defined clonal recruitment, and the avidity of TCR binding to cognate peptides in complex with MHC class I glycoproteins (pMHCI) are all key determinants of CTL response efficacy (7). Each of these factors is substantially constrained by their respective characteristics in the naive CTL precursor (CTLp) pool (7-10). During aging, both the number and TCR diversity of naïve polyclonal and epitope-specific CD8 + T-cell sets decreases (11-13). In addition, a large proportion (∼60-80%) of the remaining naïve CD8 + T cells, termed virtual memory (T VM ) cells, express high levels of CD44, traditionally regarded as a marker of T-cell activation and suggestive of proliferation (14). It is unclear whether the accumulation of T VM cells with age (15) represents preferential retention, de novo generation, or expansion of the T VM subset. TCR repertoire analyses show emerging TCR bias with age (11,13,16)...